natgillin/translations-raw huggingface dataset:
In the EU alone it is estimated that AMR costs EUR 1.5 billion annually in healthcare costs and productivity losses4. 
Ocenjeno je, da odpornost proti antimikrobikom samo v EU vsako leto povzroči 1,5 milijarde EUR stroškov zaradi potrebe po zdravstvenem varstvu in izgub produktivnosti4.
These achievements are now at risk mainly because of the excessive or inappropriate use of antimicrobials, which has led to the increasing emergence and spread of multi-resistant bacteria. 
Te dosežke pa danes ogroža predvsem prekomerna ali neustrezna raba antimikrobikov, kar je pripeljalo do naraščajočega pojavljanja in širjenja multirezistentnih bakterij.
However, no single action will, in isolation, provide an adequate solution. 
Vendar en sam ukrep, ločen od drugih, ne bo zagotovil ustrezne rešitve.
reduce the scope for falsified medicines by assisting Member States and stakeholders in the successful implementation of the safety features (unique identifier) that will appear by 2019 on the packaging of medicinal products for human use; 
zmanjšala možnosti za lažna zdravila z zagotavljanjem pomoči državam članicam in zainteresiranim stranem pri uspešnem izvajanju varnostnih elementov (edinstvene oznake), ki se bodo do leta 2019 pojavili na ovojnini zdravil za uporabo v humani medicini;
Vaccines have proven to be crucial and very cost-effective in preventing the onset and spread of infectious diseases. 
Cepiva so se dokazala kot ključna in zelo stroškovno učinkovita pri preprečevanju izbruha in širjenja infekcijskih bolezni.
The WHO, the OIE, the FAO, and the Codex Alimentarius are setting up systems and developing standards to monitor global effects. 
Organizacije SZO, OIE, FAO in Codex Alimentarius vzpostavljajo sisteme in razvijajo standarde za spremljanje globalnih učinkov.
One Health: is a term used to describe a principle which recognises that human and animal health are interconnected, that diseases are transmitted from humans to animals and vice versa and must therefore be tackled in both. 
Eno zdravje: je pojem, s katerim je opisano načelo, ki priznava, da je zdravje ljudi in živali medsebojno povezano, da se bolezni prenašajo z ljudi na živali in obratno in da je zato treba obravnavati oba vidika.
look for synergies with the UN Strategic Approach to International Chemicals Management's work on the emerging policy issue of pharmaceuticals in the environment; 
iskala sinergije s strateškim pristopom ZN k delu na področju mednarodnega upravljanja kemikalij v zvezi s porajajočim se političnim vprašanjem glede farmacevtskih proizvodov v okolju;
Since penicillin was first discovered in 1928, life-saving antimicrobials have revolutionised our society and economy. 
Antimikrobiki, ki rešujejo življenja, so po odkritju penicilina leta 1928 korenito spremenili našo družbo in gospodarstvo.
The AMR threat to public health and the social and economic burden it entails is even greater in developing countries. 
Nevarnost, ki jo odpornost proti antimikrobikom pomeni javnemu zdravju, ter družbeno in gospodarsko breme, ki ga povzroča, sta še večja v državah v razvoju.
Novel diagnostics will also make it possible to recruit the right patients in clinical trials for new treatments, making the trials more efficient. 
Nova diagnostika bo omogočila tudi iskanje ustreznih pacientov za klinična preskušanja novih zdravljenj, zaradi česar bodo ta preskušanja učinkovitejša.
Continued effort is necessary and is outlined below. 
Potrebna so nadaljnja prizadevanja, kot je opisano v nadaljevanju.
Inaction is projected to cause millions of deaths globally: it has been estimated that AMR might cause more deaths than cancer by 2050. 
Neukrepanje bi lahko povzročilo na milijone smrtnih primerov po vsem svetu: ocenjuje se, da bi zaradi odpornosti proti antimikrobikom lahko do leta 2050 umrlo več ljudi kot zaradi raka.
continue and strengthen ongoing collaboration within the Transatlantic Taskforce on Antimicrobial Resistance (TATFAR), which includes the EU, the USA, Canada, and Norway; 
nadaljevala in krepila obstoječe sodelovanje znotraj Čezatlantske delovne skupine za odpornost proti antimikrobikom (TATFAR), ki vključuje EU, ZDA, Kanado in Norveško;
encourage the EMA to review all available information on the benefits and risks of older antimicrobial agents and consider whether any changes to their approved uses in the Member States are required. 
spodbujala agencijo EMA, naj pregleda vse razpoložljive informacije o koristih in tveganjih starejših antimikrobikov ter preuči, ali je treba njihovo odobreno rabo v državah članicah kakor koli spremeniti.
help to address patient safety in hospital environments by supporting good practices in infection prevention and control; 
pomagala pri obravnavi varnosti pacientov v bolnišničnem okolju s podpiranjem dobrih praks pri preprečevanju in obvladovanju okužb;
AMR is a serious challenge, in the EU and globally. 
Odpornost proti antimikrobikom predstavlja resen izziv tako v EU kot po vsem svetu.
Actions against AMR cannot succeed without the sustained involvement of stakeholders, including industry, civil society, academia, and non-governmental experts but also the European Economic and Social Committee (EESC), throughout policy development and implementation. 
Ukrepi zoper odpornost proti antimikrobikom ne morejo biti uspešni brez stalne vključenosti zainteresiranih strani, med drugim industrije, civilne družbe, univerz in nevladnih strokovnjakov, in Evropskega ekonomsko-socialnega odbora (EESO) v celoten proces oblikovanja in izvajanja politike.
The synopsis report accompanying this Communication provides an overview of the contributions received and how they have been taken into account in defining concrete actions. 
Zbirno poročilo, priloženo temu sporočilu, vsebuje pregled prejetih prispevkov in opisuje, kako so se upoštevali pri opredelitvi določenih ukrepov.
Antimicrobial resistance (AMR): is the ability of microorganisms, such as bacteria, to become increasingly resistant to an antimicrobial to which they were previously susceptible. 
Odpornost proti antimikrobikom: je sposobnost mikroorganizmov, kot so bakterije, da postanejo čedalje odpornejši proti nekemu antimikrobiku, na katerega so bili prej občutljivi.
The Commission invites the European Parliament and the Council to endorse this One Health action plan and calls on Member States and all those involved to ensure that measures to combat AMR are swiftly implemented. 
Komisija poziva Evropski parlament in Svet, naj potrdita ta akcijski načrt „eno zdravje", države članice in vse vključene strani pa poziva, naj zagotovijo, da se bodo ukrepi za boj zoper odpornost proti antimikrobikom hitro izvajali.
As requested by the Member States, the Council conclusions of 17 June 2016 call for a new and comprehensive EU action plan on AMR based on the One Health approach. 
V skladu z zahtevami držav članic sklepi Sveta z dne 17. junija 2016 pozivajo k sprejetju novega in celovitega akcijskega načrta EU o odpornosti proti antimikrobikom, ki temelji na pristopu „eno zdravje".
The systematic inclusion of AMR-related provisions is now a current practice for the Commission in all new FTAs. 
Sistematično vključevanje določb o odpornosti proti antimikrobikom je postalo sedanja praksa Komisije v vseh novih SPT.
These indicators will be developed with the support of the EU scientific agencies (see point 2.1) and will enable Member States to assess, in a clear and simple way, the progress made in the implementation of their national One Health action plans on AMR. 
Ti kazalniki se bodo razvili ob podpori znanstvenih agencij EU (glej točko 2.1) in bodo državam članicam omogočili, da na jasen in preprost način ocenijo napredek pri izvajanju svojih nacionalnih akcijskih načrtov o odpornosti proti antimikrobikom v okviru pobude „eno zdravje".
support the establishment of a European-wide sustainable clinical research network, which should speed up clinical studies on medicinal products, lower their costs, and improve coordination of clinical research; 
podprla vzpostavitev evropske trajnostne klinično-raziskovalne mreže, ki naj bi pospešila klinične študije o zdravilih, zmanjšala njihove stroške in izboljšala usklajevanje kliničnih raziskav;
Antimicrobials: include antibiotics, antivirals, antifungals and antiprotozoals. 
Antimikrobiki: vključujejo antibiotike, antivirusna zdravila, antimikotike in antiprotozoike.
To deal with the cross-border health threat of AMR, it is crucial to identify and share best practices and policies, so that a lack of action in one region or sector does not undermine progress made in others. 
Pri obravnavanju čezmejnih nevarnosti za zdravje zaradi odpornosti proti antimikrobikom je ključno, da se opredelijo in delijo najboljše prakse in politike, da pomanjkanje ukrepanja v eni regiji ali sektorju ne bi oviralo napredka v drugih.
Drugs for bad bugs: confronting the challenges of antibacterial discovery Nature Reviews Drug Discovery 6, 29-40 (January 2007)] 
[16: Payne et al. Drugs for bad bugs (Zdravila za slabe bacile): confronting the challenges of antibacterial discovery (spopadanje z izzivi odkritja antimikrobikov), Nature Reviews Drug Discovery 6, 29-40 (januar 2007).]
Despite all this, incidences of infections resistant to multidrug therapies and last-resort treatments have significantly increased in the EU in recent years. 
Kljub vsemu temu pa se je incidenca okužb, odpornih proti zdravljenjem z več zdravili in zadnjim možnim oblikam zdravljenja, v zadnjih letih v EU bistveno povečala.
New economic models need to be developed to incentivise antimicrobial discovery and development while reconciling these incentives with responsible use. 
Razviti je treba nove gospodarske modele, da bi se spodbudila odkrivanje in razvoj antimikrobikov ob sočasnem usklajevanju teh spodbud z odgovorno rabo.
Promote the prudent use of antimicrobials 
Spodbujanje preudarne rabe antimikrobikov
The One Health approach also encompasses the environment, another link between humans and animals and likewise a potential source of new resistant microorganisms. 
Pristop „eno zdravje" zajema tudi okolje, tj. še eno vez med ljudmi in živalmi, ki je prav tako tudi potencialni vir novih odpornih mikroorganizmov.
AMR already presents a serious social and economic burden. 
Odpornost proti antimikrobikom že predstavlja resno družbeno in gospodarsko breme.
As one of the largest markets for agricultural products, the EU can play a major role in promoting its AMR-related standards, measures in food production, and standards on animal welfare, e.g. through its bilateral Free Trade Agreements (FTAs). 
EU ima lahko kot eden največjih trgov kmetijskih proizvodov pomembno vlogo pri spodbujanju standardov, povezanih z odpornostjo proti antimikrobikom, ukrepov na področju proizvodnje živil in standardov glede dobrobiti živali, npr. prek dvostranskih sporazumov o prosti trgovini (SPT).
In line with this initiative, regular discussions among stakeholders will encourage them to develop and share their strategies against AMR. 
V skladu s to pobudo jih bodo redne razprave med zainteresiranimi stranmi spodbudile, da razvijejo in izmenjujejo svoje strategije za boj zoper odpornost proti antimikrobikom.
Previously deadly diseases have become routine ailments, requiring little more than a brief treatment. 
Nekoč smrtonosne bolezni so postale povsem običajne lažje zdravstvene težave, ki zahtevajo zgolj kratko zdravljenje.
Effective action against the rise of AMR will mitigate its negative impact on the economy and can therefore be considered a contribution to economic growth, to sustainable healthcare budgets by reducing healthcare costs and to a productive and healthy population. 
Učinkovito ukrepanje zoper naraščajočo odpornost proti antimikrobikom bo ublažilo negativen vpliv na gospodarstvo, zato lahko šteje za prispevek h gospodarski rasti, vzdržnim proračunom za zdravstveno varstvo z zmanjševanjem stroškov zanj ter produktivnemu in zdravemu prebivalstvu.
This is a major cause for the inappropriate use of antimicrobials in humans and animals. 
To je glavni vzrok za neustrezno rabo antimikrobikov pri ljudeh in živalih.
intensifying EU efforts worldwide to shape the global agenda on AMR and the related risks in an increasingly interconnected world. 
okrepitev prizadevanj EU po vsem svetu za oblikovanje globalne agende o odpornosti proti antimikrobikom in povezanih tveganjih v medsebojno vedno bolj povezanemu svetu.
Resistance to antivirals, such as those used to treat HIV, is also increasing. 
Povečuje se tudi odpornost proti antivirusnim zdravilom, kakršna se na primer uporabljajo za zdravljenje virusa HIV.
This makes AMR a complex epidemiological issue. 
Zato je odpornost proti antimikrobikom kompleksno epidemiološko vprašanje.
[7: World Bank, 2016, ‘Drug-Resistant Infections: A Threat to Our Economic Future', Washington, DC.][8: http://www.un.org/sustainabledevelopment/sustainable-development-goals] 
[7: Svetovna banka, 2016, „Drug-Resistant Infections: A Threat to Our Economic Future" (Okužbe, odporne proti zdravilom: grožnja naši gospodarski prihodnosti), Washington, DC.][8: http://www.un.org/sustainabledevelopment/sustainable-development-goals]
Other control measures, such as vaccination, could also reduce the occurrence and spread of certain diseases, limiting the need for antimicrobials. 
Drugi ukrepi za obvladovanje, kot je cepljenje, bi tudi lahko zmanjšali pojavljanje in širjenje določenih bolezni, s tem pa omejili potrebo po antimikrobikih.
However, when any new antimicrobial treatment enters the market and is sold and used in large quantities, resistance can be expected to develop quickly. 
A kadar na trg vstopi antimikrobik, ki se prodaja in uporablja v velikih količinah, je mogoče pričakovati hiter razvoj odpornosti.
Most of the actions can be done by adapting and reinforcing existing actions for a more integrated, comprehensive and effective approach to combating AMR. 
Večino ukrepov je mogoče izvesti s prilagajanjem in okrepitvijo obstoječih ukrepov za doseganje bolj povezanega, celovitejšega in učinkovitejšega pristopa k boju zoper odpornost proti antimikrobikom.
Digital technologies for testing biomedical products and innovation in eHealth should also be scaled up, e.g. by supporting innovation procurement as well as supporting SMEs. 
Nadgraditi bi bilo treba tudi digitalne tehnologije za testiranje biomedicinskih proizvodov in inovacij na področju e-zdravja, npr. s podpiranjem javnih naročil na področju inovacij in MSP.
Further support and assistance to EU Member States to address differences and foster cooperation, more efficient and coordinated research to improve knowledge and develop solutions, and a continued strong EU voice at global level, were also recommended. 
Priporočena je bila tudi dodatna podpora in pomoč državam članicam EU za spopadanje z razlikami in spodbujanje sodelovanja, učinkovitejših in bolj usklajenih raziskav za izboljšanje znanja in razvoj rešitev ter nadaljnje odločno nastopanje EU na svetovni ravni.
continue to support research into the development of new effective preventive vaccines for humans and animals; 
še naprej podpirala raziskave, usmerjene v razvoj novih učinkovitih preventivnih cepiv za ljudi in živali;
advocate EU standards and measures for tackling AMR in trade agreements and incorporate them into cooperative arrangements in trade agreements; 
zagovarjala standarde in ukrepe EU za obravnavanje problema odpornosti proti antimikrobikom v trgovinskih sporazumih in jih vključevala v dogovore o sodelovanju v okviru trgovinskih sporazumov;
analyse the feasibility of setting up a global AMR clinical studies network in collaboration with G7 members; 
analizirala izvedljivost vzpostavitve svetovne mreže kliničnih študij o odpornosti proti antimikrobikom v sodelovanju s članicami skupine G7;
The action plan will thus support the EU and its Member States in delivering innovative, effective and sustainable responses to AMR. 
Akcijski načrt bo tako podprl EU in njene države članice pri oblikovanju inovativnih, učinkovitih in trajnostnih odzivov na odpornost proti antimikrobikom.
It is also crucial to prevent falsified or counterfeit antimicrobial products from entering the supply chain and harming humans or animals. 
Ključno je tudi, da se prepreči vstop lažnih ali ponarejenih antimikrobikov v dobavno verigo in škoda, ki jo lahko povzročijo ljudem ali živalim.
Such actions, often referred to as ‘antimicrobial stewardship' actions, are in place in some sectors (e.g. EU guidelines for the prudent use of antimicrobials in veterinary medicine) but are not sufficiently developed for all situations in which antimicrobials are used. 
Taki ukrepi, ki se pogosto imenujejo ukrepi za „usmerjanje rabe antimikrobikov", se v nekaterih sektorjih že izvajajo (npr. smernice EU za preudarno rabo antimikrobikov v veterinarski medicini), vendar niso zadosti razviti, da bi ustrezali v vseh primerih, v katerih se antimikrobiki uporabljajo.
[27: JA-04-2016 - Antimicrobial resistance and Health Care Associated Infections] 
[27: JA-04-2016 - Odpornost proti antimikrobikom in okužbe, povezane z zdravstveno oskrbo.]
High levels of AMR in bacteria linked to numerous common infections (e.g. urinary tract infections, pneumonia, tuberculosis and gonorrhoea) have been observed in all WHO regions. 
Visoke ravni odpornosti proti antimikrobikom pri bakterijah, povezanih s številnimi pogostimi okužbami (npr. okužbami urinarnega trakta, pljučnico, tuberkulozo in gonorejo), so zaznane v vseh regijah SZO.
promote international regulatory convergence between the EMA and other regulatory agencies such as the US Food and Drug Administration (FDA) and the Japan Pharmaceuticals and Medical Devices Agency (PMDA) on development plans for new promising antimicrobials. 
spodbujala mednarodno približevanje zakonodaj med agencijo EMA in drugimi regulativnimi agencijami, kot sta Uprava za živila in zdravila Združenih držav (FDA) in japonska agencija za farmacevtske izdelke in medicinske pripomočke, v zvezi z načrti za razvoj novih obetavnih antimikrobikov.
Similarly, in the diagnostics sector, the development and uptake of novel diagnostics requires new models that take account of the relatively high price of diagnostics compared to the currently low price of antimicrobials. 
Podobno v sektorju diagnostike razvoj in uporaba nove diagnostike zahteva nove modele, ki upoštevajo sorazmerno visoke cene diagnostike v primerjavi z antimikrobiki, ki so trenutno na voljo po nizki ceni.
maximise the use of data from existing monitoring, e.g. Watch List monitoring under the Water Framework Directive, to improve knowledge of the occurrence and spread of antimicrobials in the environment, including by using the Information Platform for Chemical Monitoring (IPCheM) to access relevant monitoring data; 
čim bolj povečala uporabo podatkov iz obstoječih spremljanj, npr. spremljanja v okviru nadzornega seznama na podlagi okvirne direktive o vodah, da se izboljša znanje o pojavu in širjenju antimikrobikov v okolju, vključno z uporabo informacijske platforme za spremljanje kemikalij (IPCheM) za dostop do ustreznih podatkov o spremljanju;
encourage the uptake of diagnostics in medical and veterinary practice, e.g. through innovation procurement. 
spodbujala uporabo diagnostike v medicinski in veterinarski praksi, npr. prek javnih naročil na področju inovacij.
The action plan will also strategically reinforce the research agenda on AMR and actively promote global action. 
Obenem bo tudi strateško okrepil raziskovalni program o odpornosti proti antimikrobikom in aktivno spodbujal globalno ukrepanje.
There is scope for more collaboration and closer ties with these partners to build consensual activities, share experiences and align approaches, for the benefit of all sides. 
Obstajajo možnosti za tesnejše sodelovanje in tesnejše vezi s temi partnerji, da bi se vzpostavila sporazumna dejanja, izmenjevale izkušnje in usklajevali pristopi v korist vseh udeleženih strani.
Improve knowledge on detection, effective infection control and surveillance 
Izboljšanje znanja o odkrivanju ter učinkovitem obvladovanju in nadzoru okužb
adopt an EU strategic approach to pharmaceuticals in the environment; 
sprejela strateški pristop EU k farmacevtskim snovem v okolju;
Such novel diagnostics are in the process of entering the market but more tests are needed to guide a more efficient use of existing antimicrobials in the human and animal health sectors. 
Takšna nova diagnostika je v fazi vstopa na trg, vendar so potrebni dodatni testi za usmerjanje učinkovitejše rabe obstoječih antimikrobikov v sektorjih zdravja ljudi in zdravja živali.
Without effective action to reverse current trends, we could face a return to the pre-antibiotic era, with simple wounds and infections causing significant harm and even death and routine medical procedures becoming very high risk. 
Brez učinkovitih ukrepov, ki bi zaustavili trenutne trende, bi nam lahko grozila vrnitev v čas pred obstojem antibiotikov: že manjše rane in okužbe bi povzročile veliko škodo in celo smrt, rutinski medicinski posegi pa bi pomenili zelo veliko tveganje.
To assist with and accelerate this collaboration, in early 2017 the Commission set up an AMR One Health network of government experts from the human health, animal health, and environmental sectors, as well as the EU scientific agencies working in the human and animal health sectors (ECDC, EMA, and EFSA). 
Da bi pomagala pri tem sodelovanju in ga tudi spodbudila, je Komisija v začetku leta 2017 vzpostavila mrežo „eno zdravje" zoper odpornost proti antimikrobikom, ki jo sestavljajo vladni strokovnjaki iz sektorjev zdravja ljudi, zdravja živali in okolja ter znanstvenih agencij EU iz sektorjev zdravja ljudi in zdravja živali (ECDC, EMA in EFSA).
It takes into account the priorities set out in the WHO Global Action Plan on AMR, the JPIAMR and national action plans. 
Upošteva prednostne naloge, ki so določene v globalnem akcijskem načrtu SZO o odpornosti proti antimikrobikom, programu JPIAMR in nacionalnih akcijskih načrtih.
Nevertheless, it continues to develop and spread across the world. 
Kljub temu se odpornost proti antimikrobikom še naprej razvija in širi po vsem svetu.
EU involvement and collaboration with multilateral organisations such as the WHO, the OIE, the FAO and international forums should therefore be intensified in order to contribute to regional and global action on AMR, following the One Health approach. 
Zaradi tega bi bilo treba okrepiti vključenost in sodelovanje EU z večstranskimi organizacijami, kot so SZO, OIE, FAO in mednarodni forumi, da bi se zagotovil prispevek regionalnemu in globalnemu ukrepanju zoper odpornost proti antimikrobikom v skladu s pristopom „eno zdravje".
Candidate countries and potential candidates benefiting from a pre-accession strategy have also made commitments regarding alignment and implementation of EU legislation related to AMR, as have the neighbouring countries to which the European Neighbourhood Policy (ENP) applies or who have an Association Agreement with the EU. 
Države kandidatke in potencialne kandidatke, ki jim predpristopna strategija prinaša koristi, so prav tako dale zavezo uskladitvi in izvajanju zakonodaje EU v zvezi z odpornostjo proti antimikrobikom, kot so storile tudi sosednje države, za katere se uporablja evropska sosedska politika (ESP) ali ki so z EU sklenile pridružitveni sporazum.
The EU was quick to recognise the importance of tackling AMR, as the 2001 Community strategy against AMR shows. 
EU je hitro prepoznala pomen obravnave odpornosti proti antimikrobikom, kar kaže strategija Skupnosti proti antimikrobni odpornosti iz leta 2001.
Shaping the global agenda 
Oblikovanje globalne agende
This implies properly training of Member States' staff involved in official control activities and keeping them up to date on all aspects of EU legislation related to AMR in order to ensure that controls are carried out uniformly and objectively in all Member States. 
To pomeni ustrezno usposabljanje osebja držav članic, ki so vključeni v dejavnosti uradnega nadzora, in redno seznanjanje tega osebja z vsemi vidiki zakonodaje EU o odpornosti proti antimikrobikom za zagotovitev enotnega in nepristranskega izvajanja nadzora v vseh državah članicah.